SCHEMBL2298646

SCHEMBL2298646

COCCOc1cccc2c1CC[N]C2

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TIPARP Q7Z3E1 1/20 0.41
SCN9A Q15858 1/20 0.37
HRH3 Q9Y5N1 2/20 0.36
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ALDH1A1 P00352 1/20 0.35
HTR1A P08908 1/20 0.34
HTR1D P28221 1/20 0.34
HTR1B P28222 1/20 0.34
GRM7 Q14831 1/20 0.34
KDM1A O60341 3/20 0.34
S1PR5 Q9H228 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
CYP19A1 P11511 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2299447 0.81 DRD2 (0.49) DRD2DRD3ADRA2ACYP19A1
SCHEMBL2301748 0.77 SCN9A (0.36) SCN9AADRA2AADRA2BADRA2CALDH1A1
SCHEMBL14861020 0.75 HTR2C (0.42) TIPARPSCN9AALDH1A1GRM7KDM1A
SCHEMBL4718360 0.73 HRH3 (0.48) TIPARPHRH3MAOB
SCHEMBL5651493 0.73 KDM1A (0.38) TIPARPSCN9AALDH1A1GRM7KDM1A
SCHEMBL9404768 0.72 MAPK1 (0.40) DRD2ALDH1A1
SCHEMBL30101569 0.71 HRH3 (0.45) TIPARPHRH3HTR1AHTR1DHTR1B
SCHEMBL2299356 0.71 CCR3 (0.33) SCN9A
SCHEMBL3250725 0.71 NPC1 (0.32) ALDH1A1
SCHEMBL21659368 0.71 HRH3 (0.61) TIPARPHRH3MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2536689-A1 ARYL CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS FOR TREATMENT OF PAIN Amgen Inc. (US) 2012-12-26 EP disclosed
WO-2011103196-A1 ARYL CARBOXAMIDE DERIVATIVES AS SODIUM CHANNEL INHIBITORS FOR TREATMENT OF PAIN AMGEN INC. (US) 2011-08-25 WO disclosed